Related Experiment Videos
Indications of implantable defibrillator
1Department of Cardiology, Hopital Lariboisière, Paris, France.
Journal of Interventional Cardiology
|November 4, 1995
Summary
Implantable cardioverter defibrillators (ICDs) effectively treat life-threatening ventricular arrhythmias and prevent sudden cardiac death. These devices remain crucial despite advancements in antiarrhythmic drugs and other therapies.
Area of Science:
- Cardiology
- Biomedical Engineering
Background:
- Ventricular tachyarrhythmias, including ventricular tachycardia and fibrillation, pose a serious risk of sudden cardiac death.
- Despite advancements in antiarrhythmic medications, radiofrequency ablation, and surgical interventions, the prognosis for patients with severe ventricular tachyarrhythmias remains guarded.
Purpose of the Study:
- To highlight the critical role of implantable cardioverter defibrillators (ICDs) in managing severe ventricular tachyarrhythmias.
- To underscore the demonstrated efficacy of ICDs in preventing sudden cardiac death.
Main Methods:
- Review of existing literature on ventricular tachyarrhythmias and their treatment modalities.
- Analysis of the clinical impact and established benefits of implantable cardioverter defibrillators.
Main Results:
- Implantable cardioverter defibrillators are proven to detect and terminate episodes of ventricular tachycardia and fibrillation.
- The efficacy of ICDs in preventing sudden cardiac death in at-risk populations is well-established.
Conclusions:
- Implantable cardioverter defibrillators are indispensable therapeutic devices for patients with severe ventricular tachyarrhythmias.
- ICDs offer a vital solution for sudden cardiac death prevention, even with the availability of alternative treatments.